Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380319914> ?p ?o ?g. }
- W4380319914 abstract "Abstract EGFR exon 20 insertion (20ins)-positive non-small-cell lung cancer (NSCLC) is an uncommon disease with limited therapeutic options and dismal prognosis. Here we report the activity, tolerability, potential mechanisms of response and resistance for dual targeting EGFR 20ins with JMT101 (anti-EGFR monoclonal antibody) plus osimertinib from preclinical models and an open label, multi-center phase 1b trial (NCT04448379). Primary endpoint of the trial is tolerability. Secondary endpoints include objective response rate, duration of response, disease control rate, progression free survival, overall survival, the pharmacokinetic profile of JMT101, occurrence of anti-drug antibodies and correlation between biomarkers and clinical outcomes. A total of 121 patients are enrolled to receive JMT101 plus osimertinib 160 mg. The most common adverse events are rash (76.9%) and diarrhea (63.6%). The confirmed objective response rate is 36.4%. Median progression-free survival is 8.2 months. Median duration of response is unreached. Subgroup analyses were performed by clinicopathological features and prior treatments. In patients with platinum-refractory diseases ( n = 53), confirmed objective response rate is 34.0%, median progression-free survival is 9.2 months and median duration of response is 13.3 months. Responses are observed in distinct 20ins variants and intracranial lesions. Intracranial disease control rate is 87.5%. Confirmed intracranial objective response rate is 25%." @default.
- W4380319914 created "2023-06-13" @default.
- W4380319914 creator A5004138615 @default.
- W4380319914 creator A5007646657 @default.
- W4380319914 creator A5012200263 @default.
- W4380319914 creator A5015160591 @default.
- W4380319914 creator A5028165423 @default.
- W4380319914 creator A5028624269 @default.
- W4380319914 creator A5031265522 @default.
- W4380319914 creator A5036519850 @default.
- W4380319914 creator A5041786187 @default.
- W4380319914 creator A5044630652 @default.
- W4380319914 creator A5046131158 @default.
- W4380319914 creator A5047175539 @default.
- W4380319914 creator A5064228800 @default.
- W4380319914 creator A5066716873 @default.
- W4380319914 creator A5067007478 @default.
- W4380319914 creator A5069498085 @default.
- W4380319914 creator A5070850471 @default.
- W4380319914 creator A5073606139 @default.
- W4380319914 creator A5077703494 @default.
- W4380319914 creator A5079054808 @default.
- W4380319914 creator A5080259724 @default.
- W4380319914 creator A5084300536 @default.
- W4380319914 creator A5086270619 @default.
- W4380319914 creator A5088499165 @default.
- W4380319914 creator A5090962174 @default.
- W4380319914 creator A5091143438 @default.
- W4380319914 creator A5092143314 @default.
- W4380319914 date "2023-06-12" @default.
- W4380319914 modified "2023-10-17" @default.
- W4380319914 title "Phase 1b trial of anti-EGFR antibody JMT101 and Osimertinib in EGFR exon 20 insertion-positive non-small-cell lung cancer" @default.
- W4380319914 cites W1533487512 @default.
- W4380319914 cites W1984068087 @default.
- W4380319914 cites W2010030578 @default.
- W4380319914 cites W2019607817 @default.
- W4380319914 cites W2057151160 @default.
- W4380319914 cites W2092741708 @default.
- W4380319914 cites W2103441770 @default.
- W4380319914 cites W2108234281 @default.
- W4380319914 cites W2155943701 @default.
- W4380319914 cites W2234519782 @default.
- W4380319914 cites W2337209831 @default.
- W4380319914 cites W2400274474 @default.
- W4380319914 cites W2549768376 @default.
- W4380319914 cites W2559588208 @default.
- W4380319914 cites W2614443510 @default.
- W4380319914 cites W2734795522 @default.
- W4380319914 cites W2766316939 @default.
- W4380319914 cites W2794883050 @default.
- W4380319914 cites W2801651204 @default.
- W4380319914 cites W2802509584 @default.
- W4380319914 cites W2805535338 @default.
- W4380319914 cites W2838798742 @default.
- W4380319914 cites W2885289995 @default.
- W4380319914 cites W2898032821 @default.
- W4380319914 cites W2903556107 @default.
- W4380319914 cites W2920175805 @default.
- W4380319914 cites W2951912016 @default.
- W4380319914 cites W2969834074 @default.
- W4380319914 cites W2976090945 @default.
- W4380319914 cites W2979281156 @default.
- W4380319914 cites W2994208520 @default.
- W4380319914 cites W2998672854 @default.
- W4380319914 cites W2999801017 @default.
- W4380319914 cites W3010469101 @default.
- W4380319914 cites W3011873920 @default.
- W4380319914 cites W3037365753 @default.
- W4380319914 cites W3128485166 @default.
- W4380319914 cites W3129535020 @default.
- W4380319914 cites W3185544520 @default.
- W4380319914 cites W3190326079 @default.
- W4380319914 cites W3191219220 @default.
- W4380319914 cites W3199928453 @default.
- W4380319914 cites W3200238080 @default.
- W4380319914 cites W3205918530 @default.
- W4380319914 cites W3206796634 @default.
- W4380319914 cites W4220879423 @default.
- W4380319914 cites W4224250853 @default.
- W4380319914 cites W4226046055 @default.
- W4380319914 cites W4229376968 @default.
- W4380319914 cites W4247053599 @default.
- W4380319914 cites W4281742019 @default.
- W4380319914 cites W4282980646 @default.
- W4380319914 cites W4283326608 @default.
- W4380319914 cites W4285010659 @default.
- W4380319914 doi "https://doi.org/10.1038/s41467-023-39139-4" @default.
- W4380319914 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37308490" @default.
- W4380319914 hasPublicationYear "2023" @default.
- W4380319914 type Work @default.
- W4380319914 citedByCount "0" @default.
- W4380319914 crossrefType "journal-article" @default.
- W4380319914 hasAuthorship W4380319914A5004138615 @default.
- W4380319914 hasAuthorship W4380319914A5007646657 @default.
- W4380319914 hasAuthorship W4380319914A5012200263 @default.
- W4380319914 hasAuthorship W4380319914A5015160591 @default.
- W4380319914 hasAuthorship W4380319914A5028165423 @default.
- W4380319914 hasAuthorship W4380319914A5028624269 @default.
- W4380319914 hasAuthorship W4380319914A5031265522 @default.
- W4380319914 hasAuthorship W4380319914A5036519850 @default.